- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03555695
Kick Out Parkinson's Disease
Karate Intervention to Change Kinematic Outcomes in Parkinson's Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
For 10 weeks, eligible subjects will engage in twice-weekly karate classes, specifically designed for individuals with early to middle stage PD, focused on incorporating upper and lower limb movements in multiple directions, increasing awareness throughout the body, shifting body weight and rotation, relaxation of the muscles, improving reaction time, using complex repetitive actions to improve coordination, footwork training and centered weight shifts to help with fall prevention, and striking shields for self-defense and stress relief.
Before beginning the karate classes, each subject will attend a pre-intervention focus group during which subjects will complete an assessment focused on overall mobility, gait, balance, mood, and quality of life. Subjects will be prompted to share their thoughts on exercise, balance, and mindfulness practices in general and in PD specifically.
Following the 10 weeks of twice-weekly karate classes, subjects will attend a post-intervention assessment and focus group during which the pre-intervention assessments will be repeated and the subject's impressions about the karate classes and their effectiveness will be measured.
Finally, the study team will contact subjects 6 months post-intervention to assess continued engagement in karate or related activities and again, the subject's quality of life and global impression of change.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
United States
-
Illinois
-
Chicago, Illinois, United States, 60612
- Rush University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects will be those diagnosed with Parkinson's Disease by a treating neurologist; if the subject is seen at Rush University Medical Center, this will be verified via chart review. If the subject is seen elsewhere, he or she will be asked to have their neurologist sign a form confirming the diagnosis of Parkinson's Disease and indicating the subject's HY stage (with definitions of each stage provided on the form for providers who may not be familiar with HY staging) at the most recent visit, to be sent back to the study coordinator for eligibility verification.
- English speaking
- Living within the Chicago area
- Subjects may be untreated for Parkinson's Disease, or may be taking any individual PD medication or combination thereof. Subjects may or may not have had Deep Brain Stimulation. Subjects may or may not be receiving physical or occupational therapy. Subjects will be encouraged to maintain their same medication regimen throughout the duration of the 10-week study, however if emergent issues arise requiring medication changes, the subject will not be disqualified.
Exclusion Criteria:
- Subjects requiring an assistive device (cane, walker, wheelchair) or the assistance of another person in order to ambulate.
- Subjects with active psychosis or exhibiting symptoms of a severe psychiatric disorder.
- Subjects unable to commit to attending, or to travel to, two classes weekly for 10 weeks.
- Subjects previously participating in a karate or other martial arts program, including boxing programs for PD, in the past 30 days.
- Subjects with atypical parkinsonism, including Progressive Supranuclear Palsy, Multiple System Atrophy, Dementia with Lewy Bodies, Corticobasal Syndrome, drug-induced parkinsonism, vascular parkinsonism, or atypical parkinsonism not otherwise specified, according to the referring neurologist.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Karate Class Participants
Eligible subjects will engage in twice-weekly karate classes for 10 weeks, specifically designed for individuals with early to middle stage PD.
Subjects will also complete an in-person pre-intervention focus group and post-intervention focus group, as well as a 6 month post-intervention follow up phone call.
|
Eligible subjects will engage in twice-weekly karate classes for 10 weeks, specifically designed for individuals with early to middle stage PD, focused on incorporating upper and lower limb movements in multiple directions, increasing awareness throughout the body, shifting body weight and rotation, relaxation of the muscles, improving reaction time, using complex repetitive actions to improve coordination, footwork training and centered weight shifts to help with fall prevention, and striking shields for self-defense and stress relief.
At the pre-intervention focus group, the study logistics will be reviewed, informed consent process will occur, the subject will complete a brief, individual pre-intervention assessment focused on overall mobility, gait, balance, mood, neurological status, and quality of life, and the subjects will be prompted to share aloud their thoughts on exercise, balance, and mindfulness practices in general and in PD specifically, and any expectations or preconceptions that they have regarding karate classes for PD.
At the post-intervention focus group, the pre-intervention assessments will be readministered, along with an assessment of the subject's global impression of change.
Subjects will be prompted to share their thoughts on how the intervention impacted their overall wellbeing, balance, and mindfulness; whether the intervention achieved their expectations; and they will be asked to provide feedback for improvements.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in mobility as measured by the Timed Up & Go (TUG)
Time Frame: 10 weeks
|
The Timed Up & Go (TUG) is a well-validated, brief measure of mobility.
To complete this assessment, subjects sit in a standard arm chair and are instructed that when the team member says "Go", they should stand up from the chair, walk at their normal pace to a taped line, turn, walk back to their chair at a normal pace, and sit down again.
The study team member will record the TUG results in seconds using a stopwatch.
A lower TUG result indicates greater mobility.
Scores at the pre- and post-intervention focus groups will be compared.
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in overall well-being as measured by the Patient Global Impression of Change Scale (PGIC)
Time Frame: 10 weeks
|
The Patient Global Impression of Change Scale (PGIC) is a single-item rating scale that asks subjects to rate their overall response to the intervention using a 7-point rating scale.
Percentages of subjects endorsing each of the 7 response options will be compared.
This scale will be completed at the post-intervention focus group.
|
10 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in balance abilities as measured by the Functional Reach Test (FRT)
Time Frame: 10 weeks
|
The Functional Reach Test (FRT) is a brief, valid, reliable, and practical assessment of balance.
This test involves a yardstick being mounted on a wall at shoulder height.
The subject is asked to stand next to the yardstick, extend the arm closest to the wall at 90 degrees of shoulder flexion, and the distance is recorded.
The subject is then asked to reach as far as he or she can forward without taking a step, and the distance is recorded again.
The difference between start and end position is the reach distance.
Greater reach distances indicate better balance.
Scores at the pre- and post-intervention focus groups will be compared.
|
10 weeks
|
Change in balance abilities as measured by the Tinetti Mobility Test (TMT)
Time Frame: 10 weeks
|
The Tinetti Mobility Test (TMT) consists of 2 subscales: balance tests (9 items, scored from 0-16) and gait tests (7 items, scored from 0-12), where higher scores reflect better performance.
Scores at the pre- and post-intervention focus groups will be compared
|
10 weeks
|
Change in anxiety as measured by the Hospital Anxiety and Depression Scale (HADS)
Time Frame: 10 weeks
|
The Hospital Anxiety and Depression Scale (HADS) is a brief, 14-item highly validated scale for measuring anxiety (7 items) and depression (7 items), where scores of >8 for either anxiety or depression indicate probable symptoms.
Scores at the pre- and post-intervention focus groups will be compared.
|
10 weeks
|
Change in cognitive abilities as measured by the Symbol Digit Modalities Test (SDMT)
Time Frame: 10 weeks
|
In the Symbol Digit Modalities Test (SDMT), the subject uses a reference key to pair specific numbers with given abstract geometric figures in 90 seconds.
Scores are the correct number of pairs made in 90 seconds, with greater scores indicating greater cognitive abilities.
Scores at the pre-and post-intervention focus groups will be compared.
|
10 weeks
|
Change in short-term memory abilities as measured by the Digit Span Test (DST)
Time Frame: 10 weeks
|
The Digit Span Test (DST) tests the number of digits a subject can recall in the correct order after hearing them.
The experimenter says numbers slowly at one second intervals.
Subjects are asked to repeat the numbers in the order they were given.
A subject's digit span is the number of items they are able to report back in order correctly.
Scores at the pre-and post-intervention focus groups will be compared.
|
10 weeks
|
Sustainability of an exercise program in patients with PD
Time Frame: 6 months
|
During the six month follow-up phone call, subjects will be asked whether they have continued to participate in any structured karate or martial arts classes.
If yes, frequency and location of these classes will be asked.
If no, reasons for lack of participation will be asked.
Larger numbers of "yes" responses would indicate program sustainability.
|
6 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18012313
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
NCT06036771RecruitingParkinson's Disease and Parkinsonism
-
NCT06036433Recruiting
-
NCT06037590Not yet recruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism
-
NCT06032468RecruitingStroke | Multiple Sclerosis | Parkinson Disease
-
NCT06036368Not yet recruitingParkinson's Disease | Essential Tremor
-
NCT06032130Not yet recruiting
-
NCT06028529Not yet recruiting
-
NCT06028477Not yet recruiting
-
NCT06029686Not yet recruiting
-
NCT06021834Not yet recruitingParkinson Disease